Spectral receives ukca authorization for burn indication expected commercialization 2nd half 2024

Dallas, feb. 22, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company ”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that its predictive software deepview ai®-burn has obtained the final stage of uk conformity assessed (ukca) authorization, for aiding in burn wound diagnosis in the united kingdom.
MDAI Ratings Summary
MDAI Quant Ranking